Supplemental Figure 1 from First-in-Human Trial of Epichaperome-Targeted PET in Patients with Cancer

MLA

Steven M. Larson, et al. Supplemental Figure 1 from First-in-Human Trial of Epichaperome-Targeted PET in Patients with Cancer. Mar. 2023. EBSCOhost, https://doi.org/10.1158/1078-0432.22477818.v1.

APA

Steven M. Larson, Jason S. Lewis, Gabriela Chiosis, Hanwen Zhang, Josef J. Fox, Heiko M. Schöder, Jacqueline Bromberg, Clifford A. Hudis, Serge K. Lyashchenko, Eva M. Burnazi, Mohammad M. Uddin, Stefan O. Ochiana, Tony Taldone, Danuta Zatorska, Pat B. Zanzonico, Bradley J. Beattie, Larry Norton, Komal Jhaveri, Shanu Modi, … Mark P.S. Dunphy. (2023). Supplemental Figure 1 from First-in-Human Trial of Epichaperome-Targeted PET in Patients with Cancer. https://doi.org/10.1158/1078-0432.22477818.v1

Chicago

Steven M. Larson, Jason S. Lewis, Gabriela Chiosis, Hanwen Zhang, Josef J. Fox, Heiko M. Schöder, Jacqueline Bromberg, et al. 2023. “Supplemental Figure 1 from First-in-Human Trial of Epichaperome-Targeted PET in Patients with Cancer,” March. doi:10.1158/1078-0432.22477818.v1.